Membrane Filtration is a precise separation technology that can achieve molecular-level filtration. It is a technology that uses selective permeability of membrane pores to separate two phases. The pressure difference between the two sides of the membrane is used as a driving force to allow solvents, inorganic ions, small molecules, etc. to pass through the membrane while trapping particles and macromolecules. The application of modern separation, purification, and concentration processes is an important way to improve the economic efficiency of the pharmaceutical industry or reduce investment. Membrane separation technology uses various membranes of different properties as separation materials to separate, purify, and concentrate substances in different systems.
Global Pharmaceutical Membrane Filtration Market likely to grow with a substantial rate during the forecast period, 2020-2027. The growing adoption of single-use industries and advancements in nanofiltration technologies are projected to drive the global pharmaceutical membrane filtration market in the upcoming periods. Additionally, the upsurge in the number of drug launches and the growing adoption of generic medicines will accelerate the robust growth of the global pharmaceutical membrane filtration market in the next few years. Moreover, growing advancements in the production of large molecules and biologics are projected to impact on the growth of global pharmaceutical membrane filtration market size in the expected period.
Pharmaceutical membrane filtration units remove suspended solids, including bacteria, endotoxins, and high-molecular-weight molecules due to the chlorine tolerant and automatically backwashed at regular intervals. Furthermore, increasing the incidence of viral and chronic diseases such as anthrax, measles, influenza, tuberculosis, and chickenpox, which led to the demand for advanced drugs and vaccines. These factors will influence the growth of the global pharmaceutical membrane filtration industry. In addition, the surge in application membrane filtration in numerous stages of drug production and development ranging from production-scale development to lab research such as drug manufacture, virus removal, drug screening, sample preparation, protein separation, and lab-scale cell culturing will witness to boost the global pharmaceutical membrane filtration market growth.
Single-use technologies provide several advantages, including reduced risk of contamination, minimizes operation time, and provide ease of convenience. They are compact and take up less amount of space in the factory settings. It can be used across various applications like sterile filtration, bioburden testing, depth filtration, virus inactivation, media, and buffer preparation.
With the development of technology, single-use technologies have evolved from the early disposable containers, clarification filters, bladder sterilization filters, etc. to now almost covers the different stages of the entire pharmaceutical process and different stages of the pharmaceutical life cycle, and has been successfully applied in cell culture production, harvest clarification, purification, virus removal, concentration/dialysis and filling processes.
Nanofiltration is a membrane filtration technology between ultrafiltration and reverses osmosis, which can efficiently retain multivalent salts and organic pollutants in water. Nanofiltration can handle many water sources, including groundwater, surface water, sewage, and water sources used as pre-treatment processes for the desalination process. At present, the main application areas are the removal of natural organic matter (NOM), disinfection by-products, viruses, pesticides, arsenic, and other micro-pollutants.
Based on the product, the global Pharmaceutical Membrane Filtration market classified into Filter, Systems, and Accessories. The Systems segment predicted to grow with a higher rate during the forecast period, 2020-2027. It is owing to the growing demand for single-use systems in pharmaceutical membrane filtration, which has many benefits such as a high retention rate, less consumption of energy, low cost, and reduced cross-contamination risk.
The Filter segment will surge due to the rise in the applications of filters in the development and manufacturing processes, including sterile filtration and end-stage processes.
Based on technique, the global Pharmaceutical Membrane Filtration market segregated into Microfiltration, Ultrafiltration, Nanofiltration, Reverse Osmosis (RO), and Ion Exchange. The Microfiltration segment witnessed a higher market share in 2019 and will continue with the largest market revenue by 2027. It is primarily driven by the rise in the usages of microfiltration in concentrating, purifying, or separating macromolecules, colloids, and suspended particles from solution.
The Nanofiltration segment will be the fastest-growing segment during the forecast period. It is attributable to its unique properties, such as good interconnectivity of pores along with the high potential to incorporate on a nanoscale.
Based on material, the global Pharmaceutical Membrane Filtration market classified into Polyethersulfone, Polyvinylidene Difluoride, Nylon Membrane Filters, Polytetrafluoroethylene, Mixed Cellulose Ester & Cellulose Acetatem and Others. The Polyethersulfone segment estimated to dominate the market by 2019 due to its hydrophilic nature used in sterile filtration and viral clearance.
The Polyvinylidene Difluoride segment will grow during the forecast period by high flow rates, its low binding properties, broad chemical and temperature resistance.
Based on the application, the global Pharmaceutical Membrane Filtration market categorized into Final Product (Sterile Filtration, Protein Purification, and Others), Raw Material (Bioburden Reduction, Media Buffers, and Prefiltration), Cell Separation, Water Purification, and Air Purification. The Final Product witnessed a higher growth rate in 2019. It will generate maximum revenue by 2027, owing to swelling production of generics, the rapid growth in the biopharmaceutical industry, coupled with the increasing adoption of membrane filters in protein purification, and sterile filtration. It includes Sterile Filtration, Protein Purification, and Others.
The Cell Separation segment will cultivate during the forecast period attributable to it is used in the production of the monoclonal antibody, vaccine, therapeutic protein.
Air Purification will surge in the market during the forecast periods as it is production areas to control the recirculation of dust from manufacturing.
Based on geography, the global Pharmaceutical Membrane Filtration market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The Asia Pacific estimated to occupy the lion’s market share by 2027, owing to emerging countries like China and India that are a hub for pharmaceutical research and development coupled with their low-cost manufacturing production and government financial aid for pharmaceutical R&D.
North America will drive during the projected periods owing to the presence of key players in these regions and the growing demand for biopharmaceuticals and rising R&D expenditure by biopharmaceutical companies in these regions.
Companies such as Merck Millipore, Danaher, Sartorius Stedim Biotech, GE Healthcare, 3M Company, Thermo Fisher Scientific, Repligen Corporation, GEA Group, Parker Hannifin, Koch Membrane Systems, Graver Technologies, Porvair Plc., Novasep, Synder Corporation, Amazon Filters Ltd., Donaldson Company, Eaton Corporation, Alfa Laval, Meissner Filtration Products, and Sterlitech Corporation are the key players in the Global Pharmaceutical Membrane Filtration Market.